News summaryBarron'sOct 22, 2026, 05:29 PM

Biohaven Stock Heads for Best Day in 3 Years as FDA Agrees to Review Drug Again - Barron's

BHVNequity_marketsregulatory_action

Biohaven Stock Heads for Best Day in 3 Years as FDA Agrees to Review Drug Again Barron's